Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Matched Targeted Therapy For High-Risk Leukemias and Myelodysplastic SyndromeDisease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RecurrenceActive, not recruitingNot applicable2026-08-06NCT02670525

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Dana-Farber Cancer Institute324

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Children's Healthcare of AtlantaAtlantaUnited States47
Children's Hospital ColoradoAuroraUnited States312
Children's Hospital of PhiladelphiaPhiladelphiaUnited States1
Children's Hospital of WisconsinMilwaukeeUnited States87
Children's Hospital's and Clinics of MinnesotaMinneapolisUnited States2
Columbia University Medical centerNew YorkUnited States224
Dana Farber Cancer InstituteBostonUnited States300
Johns Hopkins HospitalBaltimoreUnited States135
Memorial Sloan Kettering Cancer CenterNew YorkUnited States1000
Roswell Park Comprehensive Cancer CenterBuffaloUnited States63
Seattle Children's HospitalSeattleUnited States281
The Children's Hospital at MontefioreThe BronxUnited States9
The University of ChicagoChicagoUnited States65
UCSF Helen Diller Family Comprehensive Cancer CenterSan FranciscoUnited States22
Washington University at St. Louis School of MedicineSt LouisUnited States1